BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/25/2024 8:51:43 AM | Browse: 232 | Download: 679
 |
Received |
|
2023-11-09 14:43 |
 |
Peer-Review Started |
|
2023-11-09 14:44 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2023-12-17 01:33 |
 |
Revised |
|
2024-01-12 15:43 |
 |
Second Decision |
|
2024-02-18 01:43 |
 |
Accepted by Journal Editor-in-Chief |
|
2024-02-20 11:56 |
 |
Accepted by Executive Editor-in-Chief |
|
2024-02-21 06:08 |
 |
Articles in Press |
|
2024-02-21 06:08 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-04-22 00:49 |
 |
Publish the Manuscript Online |
|
2024-04-25 05:24 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Basic Study |
Article Title |
Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Ling-Ling Wang, Zhan-Jin Lu, Shun-Kui Luo, Yun Li, Zhe Yang and Hong-Yun Lu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Basic and Applied Basic Research Foundation of Guangdong Province |
2020A1515010123, 2021A1515010695 |
Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province |
2019A030317011 |
|
Corresponding Author |
Hong-Yun Lu, MD, PhD, Chief Doctor, Department of Endocrinology and Metabolism, Zhuhai People’s Hospital (Zhuhai Clinical Medical College of Jinan University, the First Hospital Affiliated with Medical College of Macao University of Science and Technology), No. 79 Kangning Road, Zhuhai 519000, Guangdong Province, China. luhongyun@jnu.edu.cn |
Key Words |
Hypoxia-inducible factor-2α; Bone marrow niche; Bone mesenchymal stem cells; Osteoporosis; Osteogenic/adipogenic differentiation; Mechanistic target of rapamycin signaling pathway |
Core Tip |
This manuscript explores the role of hypoxia-inducible factor 2alpha (HIF-2α) in bone mesenchymal stem cell (BMSC) osteogenic differentiation in the bone marrow niche, a role that is still unclear and controversial, via in vivo and in vitro experiments. We verified that downregulation of HIF-2α inhibits osteogenesis in vivo by generating mice with BMSC-specific HIF-2α knockout and applying interventions such as bilateral ovariectomy, semilethal irradiation, and treatment with dexamethasone. In vitro, we found that downregulation of HIF-2α can inhibit osteogenesis and increase adipogenesis by suppressing the mechanistic target of rapamycin signaling pathway, which may lead to the identification of drug target genes for the clinical treatment of osteoporosis. |
Publish Date |
2024-04-25 05:24 |
Citation |
Wang LL, Lu ZJ, Luo SK, Li Y, Yang Z, Lu HY. Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health. World J Stem Cells 2024; 16(4): 389-409 |
URL |
https://www.wjgnet.com/1948-0210/full/v16/i4/389.htm |
DOI |
https://dx.doi.org/10.4252/wjsc.v16.i4.389 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345